Skip to Content



PDF options:  View Fullscreen   Download PDF

PDF Transcript

75 mm

42 mm
14 mm
Pharma code XXX

In this leaflet:
1. What Lamisil AT 1% Spray is and what it is used for
2. Before you use Lamisil AT 1% Spray
3. How to use Lamisil AT 1% Spray
4. Possible side effects
5. How to store Lamisil AT 1% Spray
6. Further information
1. What Lamisil AT 1% Spray is and what it is
used for
Lamisil AT 1% Spray contains the active ingredient
terbinafine which is an antifungal used to treat skin
problems caused by fungi in:
• Athlete’s foot (tinea pedis) - Athlete’s foot appears only
on the feet (usually both, but not always), where it often
appears in between the toes. It can also appear on the

54 mm

instep, soles, or other areas of the feet. The most common
type of athlete’s foot causes cracking or scaling of
the skin, but you may also have mild swelling, blisters,
or weeping ulcers. Lamisil AT 1% Spray is recommended
for athlete’s foot when it occurs between the toes.
If you have a fungal nail infection (fungus inside
and under the nail) with discolouration of the nails
and changes in nail texture (thick or flaky), you should
consult your doctor because Lamisil AT 1% Spray is
not appropriate for this type of infection.
• Dhobie itch/jock itch (tinea cruris) - Dhobie itch appears
in the groin and inner thigh area, usually on both sides
but often with one side more than the other, where it
can spread further between the legs to the buttocks, or
up towards the stomach. Dhobie itch looks like a clearly
bordered rash, which may have blisters.

Pregnancy and breast-feeding
If you are pregnant ask your doctor before using this
medicine. Do not use the spray if you are breast-feeding.
Driving and using machines
Lamisil AT 1% Spray is not expected to affect your ability to
drive or operate machinery.
Important information about some of the ingredients of
Lamisil AT 1% Spray
Propylene glycol - may cause skin reactions.
Alcohol - contains 23.5% w/w.

2. Before you use Lamisil AT 1% Spray
DO NOT use Lamisil AT 1% Spray if you have:
• an allergy (hypersensitivity) to any of the ingredients in
the product (see Section 6 and end of Section 2).
The spray is NOT recommended for children under
16 years of age.
Take special care with Lamisil AT 1% Spray
The spray is for application on the skin only.
• Avoid inhaling the product.
• Eyes, mouth or face - avoid contact of the spray.
In case of accidental contact with eyes, rinse thoroughly
with running water.
• Damaged skin - avoid application to where alcohol
(one of the ingredients) could cause stinging or irritation.
Taking other medicines
Please tell your doctor or pharmacist if you are taking
or have recently taken any other medicines, including

Pharma code XXX
75 mm

those obtained without a prescription. Do not apply
other medicines on the areas you are treating with
Lamisil AT 1% Spray.

3. How to use Lamisil AT 1% Spray
Always use this medicine exactly as described in this
leaflet or as advised by your doctor or pharmacist.
Lamisil AT 1% Spray is applied once a day, for one week
only, for all fungal infections.
• Cleanse and dry the affected areas thoroughly and wash
your hands. Treatment can be helped by keeping the
affected areas clean by regular washing and careful
drying with your own clean towels and clothes, and not
rubbing or scratching the skin.
• Remove the cap from the spray bottle - If using the
medicine for the first time, press the pump a few
times until you achieve an even spray.
• Spray enough of the solution from a distance of 5 to
10 cm to thoroughly wet the affected skin. When used
between the toes, buttocks or on the groin, the treated

GB 316888 – XXXXXXX

Read all of this leaflet carefully because it contains
important information for you.
This medicine is available without prescription. However,
you still need to use Lamisil AT 1% Spray carefully to get
the best results from it.
– Please keep this leaflet. You may need to read it again.
– Ask your pharmacist if you need more information or
– You must contact a doctor if your symptoms worsen or
do not improve after 7 days.
– If any of the side effects get serious, or if you notice any
side effect not listed in this leaflet, please tell your
doctor or pharmacist.

Pharma code XXX


75 mm


Pharma code XXX

area may be covered with a light, fresh gauze strip,
especially at night.
• Replace the cap on the spray bottle and wash your

of treatment or the infection may return.
If you have any further questions on the use of this product,
ask your doctor or pharmacist.

Even though you will not be using Lamisil AT 1% Spray
during the second week, full skin healing after the infection
has cleared will continue for up to 4 weeks. If you have not
noticed any signs of improvement within 2 weeks of first
starting treatment, please seek advice from your doctor or

4. Possible side effects

Children under 16 years
NOT recommended.
Avoid inhaling the spray.
If the product accidentally gets into your eyes, rinse
thoroughly with running water. Consult your doctor
if any discomfort persists.
If you accidently swallow Lamisil AT 1% Spray
Contact your doctor or nearest hospital emergency
department if you, or someone else, has swallowed some
spray. Take any remaining medicine and this leaflet with
you if possible. Symptoms of accidental ingestion include
headache, nausea (feeling sick), dizziness and stomach
If you forget to use Lamisil AT 1% Spray
If you miss an application, apply the spray as soon as
possible then carry on as before. If you only remember at
the time of your next application, just apply the spray and
carry on as normal. It is important to try to use the spray at
the correct times as forgotten applications could risk the
infection returning.
If you stop using Lamisil AT 1% Spray
You should not stop using the spray before the
recommended time as this may reduce the effectiveness

Like all medicines, Lamisil AT 1% Spray can cause side
effects, although not everybody gets them.
STOP using the spray and seek medical help
immediately if you have any of the following very rare
allergic reactions:
• Difficulty breathing or swallowing, swelling of the
mouth, face, lips, tongue or throat (severe allergic
• Severe itching of the skin, with red rash or raised
lumps, hives or blisters.
Common: (may affect up to 1 in 10 people): skin peeling,
Uncommon: (may affect up to 1 in 100 people): skin
lesions, scab, skin colour changes, redness, burning, pain
and irritation at the site of application.
These common and uncommon side effects are usually
harmless and you can carry on using the spray.
Rare: (may affect up to 1 in 1000 people): eye irritation,
dry skin, contact dermatitis, eczema, worsening of
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist
or nurse. This includes any possible side effects not listed
in this leaflet. You can also report side effects directly via
the Yellow Card Scheme at:
By reporting side effects you can help provide more
information on the safety of this medicine.

Pharma code XXX
75 mm

5. How to store Lamisil AT 1% Spray
Keep out of the sight and reach of children.
Do not store Lamisil AT 1% Spray above 30°C (do not
refrigerate). Keep the bottle closed and in its carton.
Do not use or keep this medicine after the expiry (EXP)
date shown on the box and container.
Medicines should not be disposed of via wastewater or
household waste. Ask your pharmacist how to dispose of
medicines no longer required. These measures will help to
protect the environment.
6. Further information
What Lamisil AT 1% Spray contains
The active ingredient is terbinafine hydrochloride 1% w/w.
The other ingredients are purified water, ethanol,
propylene glycol and cetomacrogol 1000 (see also
Section 2 ‘Important information about some of the
ingredients of Lamisil AT 1% Spray’).
What Lamisil AT 1% Spray looks like and contents of
the pack
The spray is available in white, round, 15 ml plastic bottles
with a spray pump.
Marketing Authorisation Holder
GlaxoSmithKline Consumer Healthcare (UK) Trading Limited,
Brentford, TW8 9GS, U.K.
GlaxoSmithKline Consumer Healthcare (UK) Trading Limited,
Brentford, TW8 9GS, U.K.
® Lamisil AT 1% Spray is a registered trademark owned by
or licensed to the GSK group of companies.
This leaflet was last revised in February 2016

GB 316888 – XXXXXXX

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.